ICL Israel Chemicals Ltd (ICL) - Net Assets
Based on the latest financial reports, ICL Israel Chemicals Ltd (ICL) has net assets worth ILA6.38 Billion ILA (≈ $17.11 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA12.26 Billion ≈ $32.87 Million USD) and total liabilities (ILA5.88 Billion ≈ $15.77 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore how large is ICL Israel Chemicals Ltd's balance sheet for the complete picture of this company's asset base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ILA6.38 Billion |
| % of Total Assets | 52.04% |
| Annual Growth Rate | 7.84% |
| 5-Year Change | 46.45% |
| 10-Year Change | 87.8% |
| Growth Volatility | 13.85 |
ICL Israel Chemicals Ltd - Net Assets Trend (2000–2024)
This chart illustrates how ICL Israel Chemicals Ltd's net assets have evolved over time, based on quarterly financial data. For live valuation and market cap data, see market cap of ICL Israel Chemicals Ltd.
Annual Net Assets for ICL Israel Chemicals Ltd (2000–2024)
The table below shows the annual net assets of ICL Israel Chemicals Ltd from 2000 to 2024. Explore ICL Israel Chemicals Ltd (ICL) cash flow conversion to assess how effectively this company generates cash.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ILA5.99 Billion ≈ $16.05 Million |
-0.83% |
| 2023-12-31 | ILA6.04 Billion ≈ $16.18 Million |
+5.67% |
| 2022-12-31 | ILA5.71 Billion ≈ $15.32 Million |
+20.63% |
| 2021-12-31 | ILA4.74 Billion ≈ $12.70 Million |
+15.85% |
| 2020-12-31 | ILA4.09 Billion ≈ $10.96 Million |
+0.66% |
| 2019-12-31 | ILA4.06 Billion ≈ $10.89 Million |
+3.73% |
| 2018-12-31 | ILA3.92 Billion ≈ $10.50 Million |
+33.62% |
| 2017-12-31 | ILA2.93 Billion ≈ $7.86 Million |
+10.19% |
| 2016-12-31 | ILA2.66 Billion ≈ $7.13 Million |
-16.59% |
| 2015-12-31 | ILA3.19 Billion ≈ $8.55 Million |
+6.26% |
| 2014-12-31 | ILA3.00 Billion ≈ $8.04 Million |
-18.44% |
| 2013-12-31 | ILA3.68 Billion ≈ $9.86 Million |
+8.20% |
| 2012-12-31 | ILA3.40 Billion ≈ $9.12 Million |
+9.50% |
| 2011-12-31 | ILA3.10 Billion ≈ $8.32 Million |
+17.55% |
| 2010-12-31 | ILA2.64 Billion ≈ $7.08 Million |
-5.50% |
| 2009-12-31 | ILA2.79 Billion ≈ $7.49 Million |
+11.31% |
| 2008-12-31 | ILA2.51 Billion ≈ $6.73 Million |
+34.91% |
| 2007-12-31 | ILA1.86 Billion ≈ $4.99 Million |
+6.75% |
| 2006-12-31 | ILA1.74 Billion ≈ $4.67 Million |
+16.19% |
| 2005-12-31 | ILA1.50 Billion ≈ $4.02 Million |
+22.55% |
| 2004-12-31 | ILA1.22 Billion ≈ $3.28 Million |
+28.10% |
| 2003-12-31 | ILA955.81 Million ≈ $2.56 Million |
+9.29% |
| 2002-12-31 | ILA874.58 Million ≈ $2.34 Million |
+6.23% |
| 2001-12-31 | ILA823.29 Million ≈ $2.21 Million |
-15.93% |
| 2000-12-31 | ILA979.32 Million ≈ $2.63 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to ICL Israel Chemicals Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1224.4% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ILA5.76 Billion | 100.70% |
| Common Stock | ILA549.00 Million | 9.59% |
| Other Comprehensive Income | ILA-567.00 Million | -9.91% |
| Total Equity | ILA5.72 Billion | 100.00% |
ICL Israel Chemicals Ltd Competitors by Market Cap
The table below lists competitors of ICL Israel Chemicals Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Blackstone Secured Lending Fund
NYSE:BXSL
|
$5.48 Billion |
|
Beijing Yanjing Brewery Co Ltd
SHE:000729
|
$5.49 Billion |
|
Landstar System Inc
NASDAQ:LSTR
|
$5.49 Billion |
|
Arcosa Inc
NYSE:ACA
|
$5.50 Billion |
|
Ningbo Shanshan Co Ltd
SHG:600884
|
$5.48 Billion |
|
Clal Insurance Enterprises Holdings Ltd
TA:CLIS
|
$5.47 Billion |
|
Turkcell Iletisim Hizmetleri AS ORD
IS:TCELL
|
$5.47 Billion |
|
Shandong Intco Medical Products Co Ltd
SHE:300677
|
$5.47 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ICL Israel Chemicals Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 5,768,000,000 to 5,724,000,000, a change of -44,000,000 (-0.8%).
- Net income of 407,000,000 contributed positively to equity growth.
- Dividend payments of 251,000,000 reduced retained earnings.
- Other comprehensive income decreased equity by 229,000,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ILA407.00 Million | +7.11% |
| Dividends Paid | ILA251.00 Million | -4.39% |
| Other Comprehensive Income | ILA-229.00 Million | -4.0% |
| Other Changes | ILA29.00 Million | +0.51% |
| Total Change | ILA- | -0.76% |
Book Value vs Market Value Analysis
This analysis compares ICL Israel Chemicals Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 357.02x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 2107.04x to 357.02x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2003-12-31 | ILA0.75 | ILA1584.00 | x |
| 2004-12-31 | ILA0.95 | ILA1584.00 | x |
| 2005-12-31 | ILA1.17 | ILA1584.00 | x |
| 2006-12-31 | ILA1.35 | ILA1584.00 | x |
| 2007-12-31 | ILA1.40 | ILA1584.00 | x |
| 2008-12-31 | ILA1.90 | ILA1584.00 | x |
| 2009-12-31 | ILA2.19 | ILA1584.00 | x |
| 2010-12-31 | ILA2.06 | ILA1584.00 | x |
| 2011-12-31 | ILA2.42 | ILA1584.00 | x |
| 2012-12-31 | ILA2.66 | ILA1584.00 | x |
| 2013-12-31 | ILA2.88 | ILA1584.00 | x |
| 2014-12-31 | ILA2.34 | ILA1584.00 | x |
| 2015-12-31 | ILA2.38 | ILA1584.00 | x |
| 2016-12-31 | ILA2.02 | ILA1584.00 | x |
| 2017-12-31 | ILA2.24 | ILA1584.00 | x |
| 2018-12-31 | ILA2.95 | ILA1584.00 | x |
| 2019-12-31 | ILA3.06 | ILA1584.00 | x |
| 2020-12-31 | ILA3.07 | ILA1584.00 | x |
| 2021-12-31 | ILA3.52 | ILA1584.00 | x |
| 2022-12-31 | ILA4.24 | ILA1584.00 | x |
| 2023-12-31 | ILA4.47 | ILA1584.00 | x |
| 2024-12-31 | ILA4.44 | ILA1584.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently ICL Israel Chemicals Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 7.11%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.95%
- • Asset Turnover: 0.60x
- • Equity Multiplier: 1.98x
- Recent ROE (7.11%) is below the historical average (23.04%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2000 | 10.93% | 5.46% | 0.55x | 3.65x | ILA8.54 Million |
| 2002 | 10.55% | 4.66% | 0.66x | 3.42x | ILA4.85 Million |
| 2003 | 10.87% | 4.54% | 0.76x | 3.15x | ILA8.27 Million |
| 2004 | 21.28% | 9.23% | 0.89x | 2.60x | ILA132.80 Million |
| 2005 | 28.28% | 14.14% | 0.90x | 2.23x | ILA272.90 Million |
| 2006 | 21.56% | 11.48% | 0.90x | 2.09x | ILA200.51 Million |
| 2007 | 29.84% | 13.06% | 0.88x | 2.58x | ILA356.14 Million |
| 2008 | 82.04% | 29.03% | 1.20x | 2.35x | ILA1.76 Billion |
| 2009 | 27.78% | 16.92% | 0.77x | 2.13x | ILA493.04 Million |
| 2010 | 39.11% | 18.00% | 0.89x | 2.44x | ILA762.73 Million |
| 2011 | 49.14% | 21.39% | 0.97x | 2.37x | ILA1.20 Billion |
| 2012 | 38.53% | 19.49% | 0.86x | 2.30x | ILA962.98 Million |
| 2013 | 22.40% | 13.05% | 0.79x | 2.18x | ILA453.18 Million |
| 2014 | 15.59% | 7.59% | 0.73x | 2.81x | ILA166.18 Million |
| 2015 | 16.81% | 9.42% | 0.60x | 3.00x | ILA206.20 Million |
| 2016 | -4.74% | -2.27% | 0.63x | 3.32x | ILA-379.40 Million |
| 2017 | 12.73% | 6.72% | 0.62x | 3.05x | ILA78.10 Million |
| 2018 | 32.80% | 22.32% | 0.64x | 2.31x | ILA861.90 Million |
| 2019 | 12.10% | 9.01% | 0.57x | 2.34x | ILA82.50 Million |
| 2020 | 0.28% | 0.22% | 0.52x | 2.46x | ILA-382.00 Million |
| 2021 | 17.30% | 11.26% | 0.63x | 2.45x | ILA330.30 Million |
| 2022 | 39.51% | 21.56% | 0.85x | 2.15x | ILA1.61 Billion |
| 2023 | 11.22% | 8.59% | 0.65x | 2.02x | ILA70.20 Million |
| 2024 | 7.11% | 5.95% | 0.60x | 1.98x | ILA-165.40 Million |
Industry Comparison
This section compares ICL Israel Chemicals Ltd's net assets metrics with peer companies in the Agricultural Inputs industry.
Industry Context
- Industry: Agricultural Inputs
- Average net assets among peers: $170,803,000
- Average return on equity (ROE) among peers: 10.42%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ICL Israel Chemicals Ltd (ICL) | ILA6.38 Billion | 10.93% | 0.92x | $5.48 Billion |
| Amir Marketing and Investments in Agriculture Ltd (AMRK) | $170.80 Million | 10.42% | 1.94x | $131.89 Million |
About ICL Israel Chemicals Ltd
ICL Group Ltd, together with its subsidiaries, operates as a specialty minerals and chemicals company worldwide. It operates in four segments: Industrial Products, Potash, Phosphate Solutions, and Growing Solutions. The Industrial Products segment produces bromine out of a solution that is a by-product of the potash production process, as well as bromine-based compounds; sells various grades of p… Read more